RM

Rafay Mohammed Abdul Khader

Active Director Designated Partner DIN 11614622
DIN 11614622 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Rafay Mohammed Abdul Khader

Data last updated:

Rafay Mohammed Abdul Khader is a Designated Partner at Kube Pathology And Diagnostic Services Llp (since 2026).

DIN 11614622
Primary Designation Designated Partner
First Appointment 08 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Apr 20262026Active

Board colleagues of Rafay Mohammed Abdul Khader

NameDINCompanyDesignation
Zohra Fatima Sharmilee11616188Kube Pathology And Diagnostic Services LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Kube Pathology And Diagnostic Services Llp
Premium access

Shareholding and investment profile for Rafay Mohammed Abdul Khader

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rafay Mohammed Abdul Khader

Rafay Mohammed Abdul Khader currently holds 1 directorship: Kube Pathology And Diagnostic Services Llp (Designated Partner, since 08 Apr 2026).

Rafay Mohammed Abdul Khader was first appointed on 08 Apr 2026 as Designated Partner at Kube Pathology And Diagnostic Services Llp.

The current boards of Rafay Mohammed Abdul Khader's companies include Zohra Fatima Sharmilee (Kube Pathology And Diagnostic Services Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available